In agreement with that notion, one recent study has shown that the PANX1 blocker, PBN, reduces PANX1 and β-catenin levels in breast cancer cells and suppresses their invasiveness and metastatic potential (59). This evidence concerns the gene PANX1 and breast carcinoma.